Arteriovenous Malformation Market Poised for Steady Growth, Reaching USD 4,563.64 Million by 2030 with a CAGR of 6.1%
The Arteriovenous Malformation Market is expected to reach USD 4,563.64 Million by 2030 at 6.1% CAGR during the forecast period 2022-2030. The Arteriovenous Malformation (AVM) market is witnessing significant developments in the healthcare sector, with a focus on innovative treatments for conditions such as cerebral arteriovenous malformation (CAVM). AV malformation refers to abnormal connections between arteries and veins, disrupting the normal blood flow. CAVM specifically involves these malformations in the brain, posing serious health risks. The market's current landscape is marked by a surge in research, technological advancements, and emerging therapies to address the complexities associated with AV malformations. Market Trends: Advancements in Interventional Radiology: The AV malformation market has seen a paradigm shift with the advent of cutting-edge interventional radiology techniques. Minimally invasive procedures, such as embolization and endovascul...